tiprankstipranks
Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART

Integra Lifesciences (IART) Ownership - Who Owns Integra Lifesciences?

209 Followers

Integra Lifesciences (IART) Ownership Overview

28.26%40.02%21.94%9.77%
28.26% Insiders
21.94% Other Institutional Investors
9.77% Public Companies and
Individual Investors
The ownership structure of Integra Lifesciences (IART) stock is a mix of institutional, retail and individual investors. Approximately 61.96% of the company’s stock is owned by Institutional Investors, 28.26% is owned by Insiders and 9.77% is owned by Public Companies and Individual Investors.
The ownership structure of Integra Lifesciences (IART) stock is a mix of institutional, retail and individual investors. Approximately 61.96% of the company’s stock is owned by Institutional Investors, 28.26% is owned by Insiders and 9.77% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 10, 2023
Jeffrey Mosebrook
Svp, Fin & Princ Acct Officer
Sold$52329
Jun 05, 2023
Eric Schwartz
Evp, Clo & Sec
Bought$100030
Jun 02, 2023
Jan De Witte
President & Ceo,director
Bought$299914

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$68547
Dec 31, 2023Bought$200330
Dec 31, 2023Bought$376794
Dec 31, 2023Sold$480922

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,458,873Insider13.37%296,404,461
6,445,888Institution8.24%182,676,466
6,354,263Institution8.12%180,079,813
6,350,514Institution8.12%179,973,567
3,796,022Institution4.85%107,579,263
1,818,975Institution2.33%51,549,752
1,706,656Institution2.18%48,366,631
1,686,958Insider2.16%47,808,390
1,515,940Institution1.94%42,961,740
1,262,158Institution1.61%35,769,558

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
6,445,888Institution8.24%182,676,466
3,796,022Institution4.85%107,579,263
1,818,975Institution2.33%51,549,752
1,706,656Institution2.18%48,366,631
1,515,940Institution1.94%42,961,740
1,262,158Institution1.61%35,769,558
1,225,682Institution1.57%34,735,828
1,095,000Institution1.40%31,032,300
796,433Institution1.02%22,570,911
773,220Institution0.99%21,913,055

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,257,075Institution2.89%120,708,371
2,064,612Institution2.64%73,190,495
1,695,423Institution2.17%60,102,745
2,108,804Institution2.70%59,763,505
1,142,615Institution1.46%40,505,702
1,017,773Institution1.30%36,080,053
554,090Institution0.71%15,702,911
457,825Institution0.59%12,974,761
435,529Institution0.56%12,342,892
397,859Institution0.51%11,275,324

FAQ

Who Owns Integra Lifesciences Holdings Corp. (IART)?
According to the latest TipRanks data, approximately 21.94% of the company's stock is held by institutional investors, 28.26% is held by insiders, and 9.77% is held by retail investors.
    What percentage of Integra Lifesciences Holdings Corp. (IART) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 21.94% of Integra Lifesciences Holdings Corp. (IART) stock is held by institutional investors.
      What percentage of Integra Lifesciences Holdings Corp. (IART) stock is held by retail investors?
      According to the latest TipRanks data, approximately 9.77% of Integra Lifesciences Holdings Corp. (IART) stock is held by retail investors.
        Who owns the most shares of Integra Lifesciences Holdings Corp. (IART)?
        Richard Caruso owns the most shares of Integra Lifesciences Holdings Corp. (IART).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis